Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joline Ingels

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trialsJoline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Cancer Immunology Research|June 14, 2024
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced ExhaustionStijn De Munter, Juliane L Buhl, Laurenz De Cock, et al.
The Journal of Experimental Medicine|March 20, 2023
Single-cell profiling identifies a novel human polyclonal unconventional T cell lineageLore Billiet, Laurenz De Cock, Guillem Sanchez Sanchez, et al.
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigsSofie Meulewaeter, Margo De Velder, Diethard Reckelbus, et al.
Cell Reports. Medicine|April 16, 2024
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrumJoline Ingels, Laurenz De Cock, Dieter Stevens, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cytotherapy|October 26, 2021
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trialsJoline Ingels, Laurenz De Cock, Rupert L Mayer, et al.
Cancer Immunology Research|June 14, 2024
Knocking Out CD70 Rescues CD70-Specific NanoCAR T Cells from Antigen-Induced ExhaustionStijn De Munter, Juliane L Buhl, Laurenz De Cock, et al.
The Journal of Experimental Medicine|March 20, 2023
Single-cell profiling identifies a novel human polyclonal unconventional T cell lineageLore Billiet, Laurenz De Cock, Guillem Sanchez Sanchez, et al.
Molecular Therapy. Methods & Clinical Development|June 16, 2025
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigsSofie Meulewaeter, Margo De Velder, Diethard Reckelbus, et al.
Cell Reports. Medicine|April 16, 2024
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrumJoline Ingels, Laurenz De Cock, Dieter Stevens, et al.
Pageof 2